Regenerative medicine developer Biostage cancels Nasdaq uplisting, public offering Posted on February 3, 2023 By Charlielikes Stock Market Tags:biostage, cancels, developer, market, medicine’, nasdaq, offering, public, regenerative, stock, stock market, uplisting,